Merlin (MRLN) Q2 2026 earnings — TrendMatrix coverage
MISS · WIDER LOSS-335.0% vs estimateEPS -$1.06 vs -$0.24 est
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Event detail · Q2 2026
Key numbers
- Reported EPS
- -$1.06
- Estimate
- -$0.24
- Surprise
- -335.0%
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
Report record · Q2 2026
How the report landed
Merlin (MRLN) reported a wider loss than forecast — diluted EPS of -$1.06 against the -$0.24 estimate (a 335.0% shortfall).
Around the report
Coverage in the report window
- Swarmer Posts Downbeat Q2 Results, Joins TSS, ARS Pharmaceuticals, Globant And Other Big Stocks Moving Lower In Friday’s — benzinga, 2026-08-14